Monday, October 20, 2014 Last update: 7:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Nutra Pharma Corp.

News articles for Nutra Pharma Corp.:

Tuesday, August 19, 2014

  • Nutra Pharma Provides Nyloxin(R) Marketing Updates
    CORAL SPRINGS, FL -- (Marketwired) -- 08/19/14 -- Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is announcing updates to the marketing plan for their over-the-counter (OTC) pain reliever, Nyloxin®. Nutra Pharma previously announced a commercial campaign ... read more

Wednesday, June 25, 2014

  • Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
    CORAL SPRINGS, FL -- (Marketwired) -- 06/25/14 -- Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is announcing that MyNyloxin.com, a new company that has the exclusive rights to market and distribute Nutra Pharma's over-the-counter (OTC) pain ... read more

Wednesday, May 28, 2014

  • Nutra Pharma Announces Completion of Commercials by MyNyloxin.com
    CORAL SPRINGS, FL -- (Marketwired) -- 05/28/14 -- Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is announcing that MyNyloxin.com, a new company that has the exclusive rights to market and distribute Nutra Pharma's over-the-counter (OTC) pain ... read more

Tuesday, April 22, 2014

Monday, June 24, 2013

  • Nutra Pharma Announces Launch of Pet Pain-Away for Companion Animals
    CORAL SPRINGS, FL -- (Marketwired) -- 06/24/13 -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they are in the process of launching the newest addition to their line of ... read more